Brownlow N - Search Results

1

Regulation of the cytokinesis cleavage furrow by PKCε.

Brownlow N, Pike T, Crossland V, Claus J, Parker P. Brownlow N, et al. Biochem Soc Trans. 2014 Dec;42(6):1534-7. doi: 10.1042/BST20140240. Biochem Soc Trans. 2014. PMID: 25399566 Review.

2

Protein kinase C epsilon in cell division: control of abscission.

Saurin AT, Brownlow N, Parker PJ. Saurin AT, et al. Among authors: brownlow n. Cell Cycle. 2009 Feb 15;8(4):549-55. doi: 10.4161/cc.8.4.7653. Epub 2009 Feb 19. Cell Cycle. 2009. PMID: 19197162

3

Mitotic catenation is monitored and resolved by a PKCε-regulated pathway.

Brownlow N, Pike T, Zicha D, Collinson L, Parker PJ. Brownlow N, et al. Nat Commun. 2014 Dec 8;5:5685. doi: 10.1038/ncomms6685. Nat Commun. 2014. PMID: 25483024 Free PMC article.

4

PKCɛ switches Aurora B specificity to exit the abscission checkpoint.

Pike T, Brownlow N, Kjaer S, Carlton J, Parker PJ. Pike T, et al. Among authors: brownlow n. Nat Commun. 2016 Dec 22;7:13853. doi: 10.1038/ncomms13853. Nat Commun. 2016. PMID: 28004745 Free PMC article.

5

The Aurora B specificity switch is required to protect from non-disjunction at the metaphase/anaphase transition.

Kelly JR, Martini S, Brownlow N, Joshi D, Federico S, Jamshidi S, Kjaer S, Lockwood N, Rahman KM, Fraternali F, Parker PJ, Soliman TN. Kelly JR, et al. Among authors: brownlow n. Nat Commun. 2020 Mar 13;11(1):1396. doi: 10.1038/s41467-020-15163-6. Nat Commun. 2020. PMID: 32170202 Free PMC article.

6

Author Correction: The Aurora B specificity switch is required to protect from non-disjunction at the metaphase/anaphase transition.

Kelly JR, Martini S, Brownlow N, Joshi D, Federico S, Jamshidi S, Kjaer S, Lockwood N, Rahman KM, Fraternali F, Parker PJ, Soliman TN. Kelly JR, et al. Among authors: brownlow n. Nat Commun. 2020 Jun 3;11(1):2884. doi: 10.1038/s41467-020-16468-2. Nat Commun. 2020. PMID: 32493898 Free PMC article.

7

STAT4 expression and activation is increased during mitosis in vitro and in vivo in skin- and mucosa-derived cell types: implications in neoplastic and inflammatory skin diseases.

Ferreli C, Lai C, August S, Buggy Y, Kumar P, Brownlow N, Parker P, Friedmann PS, Ardern-Jones M, Pickard C, Healy E. Ferreli C, et al. Among authors: brownlow n. J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1663-1673. doi: 10.1111/jdv.14342. Epub 2017 Aug 10. J Eur Acad Dermatol Venereol. 2017. PMID: 28516569

8

DNA replication stress: NoCut to the rescue.

Amaral N, Brownlow N, Mendoza M. Amaral N, et al. Among authors: brownlow n. Cell Cycle. 2017 Feb;16(3):233-234. doi: 10.1080/15384101.2016.1214044. Epub 2016 Jul 27. Cell Cycle. 2017. PMID: 27464067 Free PMC article. No abstract available.

9

FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance.

Taylor JR, Brownlow N, Domin J, Dibb NJ. Taylor JR, et al. Among authors: brownlow n. Oncogene. 2006 Jan 5;25(1):147-51. doi: 10.1038/sj.onc.1209007. Oncogene. 2006. PMID: 16170366

10

Novel imatinib derivatives with altered specificity between Bcr-Abl and FMS, KIT, and PDGF receptors.

Skobridis K, Kinigopoulou M, Theodorou V, Giannousi E, Russell A, Chauhan R, Sala R, Brownlow N, Kiriakidis S, Domin J, Tzakos AG, Dibb NJ. Skobridis K, et al. Among authors: brownlow n. ChemMedChem. 2010 Jan;5(1):130-9. doi: 10.1002/cmdc.200900394. ChemMedChem. 2010. PMID: 19950162

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters